Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Emad Eldin Mohamed clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Egypt register with Emad Eldin Mohamed as lead sponsor. Synced 18 Oct 2026
3Current trials
0Recruiting now
0Drugs in these trials
1Trial register
At a glance

Emad Eldin Mohamed is the lead sponsor of 3 current clinical trials in our Egypt register. None of its ClinicalTrials.gov trials is recruiting at the moment. All registered phases are Not applicable. The most-studied condition is Diabete Mellitus.

ClinicalTrials.gov trials by status

  • Active, closed3100%

Trials by phase

  • Not applicable3100%
01

Clinical trials sponsored by Emad Eldin Mohamed

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Effectiveness of a Multimodal Cognitive Rehabilitation Protocol Combined With Mechanical Periodontal Therapy in Diabetic Patients With Cognitive Impairment
NCT07870291 · ClinicalTrials.gov ↗ · Diabete Mellitus
Not applicable Active, closed 2026-02 Egypt
Comparative Effect of Virtual Reality and Core Stability Exercises in Patients With Non-specific Chronic Low Back Pain
NCT07602816 · ClinicalTrials.gov ↗ · Non Specific Low Back Pain
Not applicable Active, closed 2026-05 Egypt
Differential Effects of Aerobic and Circuit Training on Glycemic Regulation in Diabetic Children
NCT07874854 · ClinicalTrials.gov ↗ · Diabetic Children
Not applicable Active, closed 2026-03 Egypt

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Emad Eldin Mohamed trials

3 conditions
Diabete Mellitus1Non Specific Low Back Pain1Diabetic Children1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Egypt30

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Diabete Mellitus

SponsorTrials
Abbott Diabetes Care1
Ospedale San Raffaele1
University of Coimbra1

Sponsors with the most current trials registered for this condition.

05

Questions about Emad Eldin Mohamed trials

How many clinical trials does Emad Eldin Mohamed sponsor?

Emad Eldin Mohamed is the lead sponsor of 3 current trials on ClinicalTrials.gov in our Egypt register, as of the registry sync on 18 October 2026. Completed and withdrawn studies are not counted.

Are Emad Eldin Mohamed trials recruiting?

Not at the moment. None of its 3 ClinicalTrials.gov trials is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 18 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.